Clinical trial
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With…
NCT00171431 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00171431 |
|---|---|
| Title | The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) |
| Official title | The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Constipation Predominant, Irritable Bowel Syndrome (IBS-C) |
| Intervention type | Drug |
| Interventions | Tegaserod |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: